QuantuMDx Looks to Crowdfunding to Fund Handheld Medical Lab

QuantuMDx-Group-logoBritish biotech firm QuantuMDx is prepping to launch a crowdfunding campaign to support development and clinical trials of our handheld DNA sequencer described as a handheld lab. This device is said to diagnose infectious disease in under 15 minutes, tell a healthworker exactly which drug will tackle that strain of disease, and save millions of lives. The company wants to put their device to work tackling malaria, a disease which kills a child every minute.  

elaine-warburtonCEO Elaine Warburton OBE said

“Our crowdfunding campaign is unique. Not only are we looking for contributors to support this phenomenally worthy cause to help save many hundreds if not thousands of children’s lives, but we’re also offering everyone the chance to leave a lasting legacy in the fight against malaria by contributing their winning ideas to the look and feel of our device and to take part in re-naming it from the current research name of Q-POC. Who knows, perhaps we’ll find the next Jonathan Ive? ” 

QuantuMDx-devicesThe UK biotech company is developing a low cost, simple-to-use, handheld laboratory for commercialisation in 2015. The device, which reads and sequences DNA and converts it into binary code using a tiny computer chip, is ideally suited to help address the humanitarian health burden by offering molecular diagnostics at a fraction of the price of traditional testing.  Rapidly & accurately detecting and monitoring emerging drug resistance of infectious diseases such as malaria, TB and HIV will enable health professionals to immediately prescribe the most effective drug against that disease.

The company expects to launch crowdfunding on Indiegogo on February 12, 2014.

_______________________________

 

 


Have a crowdfunding offering you'd like to share? Submit an offering for consideration using our Submit a Tip form and we may share it on our site!



Sponsored Links by DQ Promote

 

 

Disclosure Quest

Reg A - Form 1-A Filings Beta

Beta. Initial Form 1-A only. Target raise is the stated Amount to be Raised, totaled. Compared with the same dates one year earlier.

YTD: Jan 1, 2026 - Nov 21, 2026 vs Jan 1, 2025 - Nov 21, 2025

Share this graph
Number of Filings140Prior 133 +5.3%
Target Raise, Total$3.56BPrior $3.68B -3.2%
This YTDYear priorChange
Filings 140 133 +5.3%
Target raise $3.56B $3.68B -3.2%

Sponsored by the Crowded Media Group the leading digital news service covering the global Fintech Industry, including digital assets, crowdfunding, tokenization, and other innovations in capital markets. email us @CrowdfundInside

Source: DisclosureQuest. Initial Form 1-A only.

Created by Crowded Media Group

This display counts initial Form 1-A filings only. It does not represent subsequent filings, including Form 1-A/A amendments or Form 1-A POS post-qualification updates filed by the issuer. Amounts are the stated Amount to be Raised on the initial filing, not capital raised and not amounts revised in later filings.

0 0 votes
Article Rating
Subscribe
Notify of
guest

This site uses Akismet to reduce spam. Learn how your comment data is processed.

0 Comments
Newest
Oldest Most Voted
 
0
Would love your thoughts, please comment.x
()
x
Send this to a friend